MLNIX
Price
$27.85
Change
+$0.13 (+0.47%)
Updated
Sep 26 closing price
Net Assets
350.82M
RNPEX
Price
$71.60
Change
+$0.37 (+0.52%)
Updated
Sep 26 closing price
Net Assets
161.39B
Interact to see
Advertisement

MLNIX vs RNPEX

Header iconMLNIX vs RNPEX Comparison
Open Charts MLNIX vs RNPEXBanner chart's image
Morgan Stanley Instl Glbl Concntr I
Price$27.85
Change+$0.13 (+0.47%)
VolumeN/A
Net Assets350.82M
American Funds New Perspective R4
Price$71.60
Change+$0.37 (+0.52%)
VolumeN/A
Net Assets161.39B
MLNIX vs RNPEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MLNIX vs. RNPEX commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLNIX is a Hold and RNPEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPEX has more cash in the bank: 161B vs. MLNIX (351M). RNPEX pays higher dividends than MLNIX: RNPEX (0.48) vs MLNIX (0.17). MLNIX was incepted earlier than RNPEX: MLNIX (9 years) vs RNPEX (23 years). MLNIX (1.06) is less costly to investors than RNPEX (0.76). MLNIX is a more actively managed with annual turnover of: 43.00 vs. RNPEX (24.00). RNPEX has a lower initial minimum investment than MLNIX: RNPEX (250) vs MLNIX (1000000). MLNIX annual gain was more profitable for investors over the last year : 18.48 vs. RNPEX (10.73). MLNIX return over 5 years is better than : 92.66 vs. RNPEX (40.31).
MLNIXRNPEXMLNIX / RNPEX
Total Expense Ratio1.000.76132%
Annual Report Gross Expense Ratio1.060.76139%
Fund Existence9 years23 years-
Gain YTD18.81417.550107%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets351M161B0%
Annual Yield % from dividends0.170.4835%
Returns for 1 year18.4810.73172%
Returns for 3 years98.9161.36161%
Returns for 5 years92.6640.31230%
Returns for 10 yearsN/A110.48-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTMX2.900.06
+2.11%
CytomX Therapeutics
SOLV71.370.91
+1.29%
Solventum Corp
EFSC58.840.22
+0.38%
Enterprise Financial Services Corp
WSBK9.560.03
+0.31%
Winchester Bancorp Inc
SPHL0.46-0.01
-2.28%
Springview Holdings Ltd